Sponsor pipeline

Liquidia Technologies, Inc. clinical trial pipeline

Get alerts when Liquidia Technologies, Inc.'s trials change

6 active trials 2 recruiting 3 Phase 3 2 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-09-03
Trial sites expanded: 16 → 36 locations
NCT07285655 A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD · Phase 3

Active trials by phase

Phase 2
1
Phase 3
3
Phase 4
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT07759804 A Study of Inhaled Treprostinil (LIQ861) in Adults With Pulmonary Arterial Hypertension… Pulmonary Arterial Hypertension (PAH) Not Yet Recruiting 2026-08-12
Phase 3
NCT07285655 A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD Pulmonary Hypertension Due to Lung Disease (Disorder) Recruiting 2026-09-02
NCT04691154 A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or… Pulmonary Arterial Hypertension Active, Not Recruiting 2026-04-01
NCT03992755 Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry… Primary Pulmonary Hypertension Active, Not Recruiting 2025-01-29
Phase 2
NCT07748000 A Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have… Raynaud's Phenomenon Secondary to Systemic Sclerosis Not Yet Recruiting 2026-08-07
Not specified
NCT06129240 An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry… Pulmonary Hypertension Recruiting 2026-06-26

Disease areas by active trials

Hypertension (5) · Scleroderma (1)

Get alerts when Liquidia Technologies, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free